The Impact of the Myeloid Response to Radiation Therapy
Radiation therapy is showing potential as a partner for immunotherapies in preclinical cancer models and early clinical studies. As has been discussed elsewhere, radiation provides debulking, antigen and adjuvant release, and inflammatory targeting of effector cells to the treatment site, thereby as...
Saved in:
Main Authors: | Michael J. Gough, Kristina Young, Marka Crittenden |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2013-01-01
|
Series: | Clinical and Developmental Immunology |
Online Access: | http://dx.doi.org/10.1155/2013/281958 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impact of the Number of Administered Systemic Treatment Lines on Local Response to Radiation Therapy for Multiple Myeloma
by: Andrea Emanuele Guerini, MD, et al.
Published: (2025-03-01) -
Urothelial Superior Vena Cava Syndrome with Limited Response to Radiation Therapy
by: Nishan Bingham, et al.
Published: (2015-01-01) -
Radiation Therapy of Carcinoma of the Esophagus
by: Thomas J Keane
Published: (1990-01-01) -
Radiation dose and fraction in immunotherapy: one-size regimen does not fit all settings, so how does one choose?
by: Marka Crittenden, et al.
Published: (2021-04-01) -
Postmastectomy Radiation Therapy: Are We Ready to Individualize Radiation?
by: Ashlyn S. Everett, et al.
Published: (2018-01-01)